Merck KGaA Terminates the License Agreement on Ceralifimod (ONO-4641) by Reaching Mutual Agreement with Ono Pharmaceutica [One less competitor in 2nd generation of S1P space] http://news.emdgroup.com/N/0/CA6B3B25E9032894C1257CFA001FE133/$File/OnoEMD.pdf